EUVIMEDObjevte EUVIMED
Open access

Neohesperidin Regulates Lipid Metabolism and Ameliorates MASLD by Targeting ECHS1

Hongyan Zhu, Tong Zhu, Min Yang iD, Xiaohui Huang, Shengwang Gao, Mingfei Li, Yang Shu, Xinran Yu, Xisong Ke iD, Jian Zhang iD, Jia Qi

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70400 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Hongyan Zhu and 10 co-authors. Institution: Department of Clinical Pharmacy, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Major MEDLINE topics: Lipid Metabolism, Hesperidin, Non-alcoholic Fatty Liver Disease, Fatty Liver. 36 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China, Young Talent Project of the Chinese Pharmaceutical Association, Young Talent Capacity Improvement Plan of the Shanghai Pharmaceutical Association.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a highly prevalent chronic liver condition globally, closely linked to disrupted lipid metabolism, yet effective targeted therapies remain elusive. While we previously reported the efficacy of ShuGan‐QieZhi Capsule against fatty liver disease, the therapeutic potential of its active component, Neohesperidin (NH), in MASLD was unknown. Here, we demonstrate that NH effectively alleviates lipid accumulation in high‐fat diet (HFD)‐induced mice and palmitic acid (PA)‐treated hepatocytes. Mechanistically, NH directly binds to PHE248 of ECHS1, a key enzyme in fatty acid β‐oxidation, and inhibits its ubiquitin‐proteasome‐mediated degradation, thereby stabilizing ECHS1 and promoting lipid catabolism. Additionally, NH modulates the PPARα signaling pathway, contributing to its overall therapeutic effect. Our findings not only identify ECHS1 as a promising therapeutic target for MASLD but also propose NH as a first‐in‐class small molecule that directly stabilizes ECHS1, providing a novel strategy against MASLD by targeting protein stability to restore lipid homeostasis.

Subjects

MeSH terms (MEDLINE)

Lipid MetabolismHesperidinNon-alcoholic Fatty Liver DiseaseFatty LiverAnimalsMicePPAR alphaDiet, High-FatHepatocytesMice, Inbred C57BLMaleHumansSignal TransductionPalmitic Acid

Author keywords

ECHS1Neohesperidinlipid metabolismmetabolic dysfunction‐associated steatotic liver disease (MASLD)

Substances

HesperidinneohesperidinPPAR alphaPalmitic Acid

Authors and institutions

  • Department of Clinical Pharmacy, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Center for Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID profiles: Min Yang, Xisong Ke, Jian Zhang

Funding

  • National Natural Science Foundation of China
  • Young Talent Project of the Chinese Pharmaceutical Association
  • Young Talent Capacity Improvement Plan of the Shanghai Pharmaceutical Association
  • Discipline Construction of Pudong Health Bureau of Shanghai-Discipline Group of Cerebrovascular System Diseases

Cite

APA

Zhu, H., Zhu, T., Yang, M., Huang, X., Gao, S., Li, M., Shu, Y., Yu, X., Ke, X., Zhang, J., & Qi, J. (2026). Neohesperidin Regulates Lipid Metabolism and Ameliorates MASLD by Targeting ECHS1. Phytotherapy Research. https://doi.org/10.1002/ptr.70400

Vancouver

Zhu H, Zhu T, Yang M, Huang X, Gao S, Li M, et al. Neohesperidin Regulates Lipid Metabolism and Ameliorates MASLD by Targeting ECHS1. Phytotherapy Research. 2026. doi:10.1002/ptr.70400

BibTeX
@article{Zhu2026,
  author = {Zhu, Hongyan and Zhu, Tong and Yang, Min and Huang, Xiaohui and Gao, Shengwang and Li, Mingfei and Shu, Yang and Yu, Xinran and Ke, Xisong and Zhang, Jian and Qi, Jia},
  title = {Neohesperidin Regulates Lipid Metabolism and Ameliorates MASLD by Targeting ECHS1},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70400}
}
Start for free →